Psychiatr. praxi. 2016;17(3):108-110 | DOI: 10.36290/psy.2016.028

Treatment of farmacoresistant depression in polymorbid patient

MUDr. Jana Komorousová, Ph.D.
Psychordinace Smrková s. r. o., Plzeň

Case report presents the treatment of patients with type 2 diabetes who suffered from depression and whose psychological state after several years of unsuccessful treatment significantly improved with a combination of agomelatine and venlafaxine. Thanks to this medication the patient was improved in both psychological state and metabolic state - significantly decreased body weight and glycated hemoglobin, which is for treatment of diabetes desirable. Case report shows the importance to treat patients for sufficiently long period (if treatment well tolerated) untill the therapeutical effect land. Furthermore, agomelatine appeared to be suitable for the treatment of depression in polymorbid patients with drug combination, thanks to its profile of drug interactions and low rate of side effects.

Keywords: diabetes mellitus, depression, antidepressant, venlafaxine, agomelatine

Published: October 26, 2016  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Komorousová J. Treatment of farmacoresistant depression in polymorbid patient. Psychiatr. praxi. 2016;17(3):108-110. doi: 10.36290/psy.2016.028.
Download citation

References

  1. Tůma I. Deprese a diabetes. Remedia 2014; 24(2): 94-98.
  2. Češková E. Vliv léčby antidepresivy na hmotnost. Psychiatrie pro praxi; 2009; 10(5): 220-223.
  3. Svačina Š. Antidepresiva a jiná psychofarmaka ve vztahu k diabetu. Medicina po promoci Suppl. 2/2007. Medicaltribune.cz.
  4. Janů L. Anhedonie - nežádoucí účinek, reziduální symptom nebo známka stability? Psychiatr. praxi; 2013; 14(4): 164-166.
  5. Winkley K, Landau S, Eisler I, Ismail K. Psychological interventions to improve glycaemic control in patients with type 1 diabetes: systematic revie wand meta-analysis od randomised controlled trials. BMJ 2006; 333: 65. Go to original source... Go to PubMed...




Psychiatry for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.